Vitamin D Potentially Inhibition of Prostate Cancer

admin   March 30, 2015   Comments Off on Vitamin D Potentially Inhibition of Prostate Cancer

Vitamin D is known as vitamin boosters bones and teeth. In fact, the benefits of this vitamin is very diverse, including to slow prostate cancer.

A little research shows that vitamin D supplementation may slow or prevent the possibility of early stage prostate cancer development.

“Vitamin D reduces inflammation in tissue, due to inflammation or inflammation is the trigger cancer,” said lead investigator and professor of pediatrics, biochemistry, and molecular biology at the Medical University of South Caroline Charleston, Bruce Hollis.

For this study, the researchers gave 4,000 IU of vitamin D daily or inactive placebo to 37 men randomized to undergo surgical removal of the prostate. Supplementation was carried out for 60 days before surgery.

When the prostate gland checked after the surgery, the researchers found that men who received vitamin D had an increase in their prostate tumors. Meanwhile, the tumor in the placebo group remained the same or even worse.

“More than 60 percent of those taking vitamin supplements, vitamin D is actually making them better cancer,” said Hollis.

Hollis reported that in some cases other tumors shrank and disappeared. However, this study was small and the results of larger studies are not predictable in a few years.

Doctors often recommend future ‘wait and see’ in men who have early stage prostate tumors or malignant. However, many patients and their families are not comfortable waiting and opted for surgery before getting needed medical care.

These findings suggest vitamin D to help reduce the need for treatment is radiation.

On the other hand, the head of radiation oncology at Brigham and Women’s Hospital in Boston, Anthony D’Amico said that the study was too small to reach definitive conclusions about the benefits of vitamin D in the fight against prostate cancer.

“It is too early when directly make conclusions,” he said. D’Amico added, the result is also still need to be retested to more patients.

The results of this study is scheduled for presentation at the annual meeting of the American Chemical Society in Denver, USA. The data and conclusions will be presented at the meeting until published in a medical journal.